PRNewswire · Sep 2025
LEAH Labs and the University of Missouri reported world-first remission in two canine B-cell lymphoma patients treated with CAR-T cells isolated using Akadeum's kit.
Living therapies for pets first, and their people next
Company research
Public company, workplace, funding, and market signals
Overview
LEAH Labs is a translational veterinary biotechnology company building designer cell therapies for dogs, starting with CAR-T for B-cell lymphoma, and using its virus-free GeneWeld gene-editing platform and One Health approach to inform human cancer therapies.
Primary product
CAR-T cell therapy for dogs with B-cell lymphoma
Founded
2018
Headquarters
Eagan, Minnesota, United States
Team size
1-10 employees
Industry
Biotechnology Research
Sub-industry
Cell therapy / veterinary oncology
Offices
Eagan, Minnesota, United States
Open Positions
0 jobs at LEAH Labs
No open positions
Check back later for new openings